NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,593,000 | +178.0% | 44,508 | +101.5% | 0.00% | – |
| Q3 2014 | $573,000 | -53.1% | 22,086 | -40.2% | 0.00% | -100.0% |
| Q2 2014 | $1,221,000 | +1145.9% | 36,952 | +1034.5% | 0.00% | – |
| Q1 2014 | $98,000 | +14.0% | 3,257 | +14.2% | 0.00% | – |
| Q4 2013 | $86,000 | -89.0% | 2,852 | -88.4% | 0.00% | -100.0% |
| Q3 2013 | $779,000 | +63.3% | 24,490 | -22.5% | 0.00% | – |
| Q2 2013 | $477,000 | – | 31,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
| Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
| Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
| Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
| OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
| First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
| Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
| Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
| FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |